Credit Suisse Ag Amneal Pharmaceuticals, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 155,646 shares of AMRX stock, worth $1.81 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

155,646

Previous 155,646 -0.0%

Holding current value

$1.81 Million

Previous $944,000 0.11%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$3.36 - $6.21 $522,970 - $966,561	155,646 New	155,646 $944,000
Q1 2023 May 10, 2023	BUY	$1.27 - $2.7 $31 - $67	25 Added 0.04%	61,879 $86,000
Q4 2022 Feb 13, 2023	SELL	$1.96 - $2.61 $480 - $639	-245 Reduced 0.39%	61,854 $123,000
Q3 2022 Nov 10, 2022	BUY	$2.02 - $3.62 $1,193 - $2,139	591 Added 0.96%	62,099 $124,000
Q2 2022 Aug 12, 2022	BUY	$3.01 - $4.46 $1,670 - $2,475	555 Added 0.91%	61,508 $196,000

Q1 2022 May 16, 2022	BUY	$3.9 - $4.89 $18,415 - $23,090	4,722 Added 8.4%	60,953 $255,000
Q4 2021 Feb 14, 2022	SELL	$3.95 - $5.85 $9,136 - $13,531	-2,313 Reduced 3.95%	56,231 $270,000
Q3 2021 Nov 12, 2021	BUY	$4.31 - $5.64 $18,455 - $24,150	4,282 Added 7.89%	58,544 $313,000
Q2 2021 Aug 16, 2021	SELL	$5.12 - $6.82 $49,556 - $66,010	-9,679 Reduced 15.14%	54,262 $280,000
Q1 2021 May 14, 2021	SELL	$4.74 - $7.38 $214,840 - $334,498	-45,325 Reduced 41.48%	63,941 $430,000
Q4 2020 Feb 12, 2021	BUY	$3.95 - $5.42 $173,772 - $238,442	43,993 Added 67.4%	109,266 $499,000
Q3 2020 Nov 13, 2020	SELL	$3.54 - $5.27 $61,242 - $91,170	-17,300 Reduced 20.95%	65,273 $253,000
Q2 2020 Aug 12, 2020	SELL	$2.87 - $5.46 $533,911 - $1.02 Million	-186,032 Reduced 69.26%	82,573 $393,000
Q1 2020 May 13, 2020	BUY	$2.46 - $5.35 $435,862 - $947,912	177,180 Added 193.8%	268,605 $935,000
Q4 2019 Feb 12, 2020	BUY	$2.65 - $5.56 $83,938 - $176,113	31,675 Added 53.01%	91,425 $441,000
Q3 2019 Nov 12, 2019	SELL	$2.29 - $7.1 $87,771 - $272,128	-38,328 Reduced 39.08%	59,750 $174,000
Q2 2019 Aug 14, 2019	SELL	$6.44 - $14.29 $221,420 - $491,318	-34,382 Reduced 25.96%	98,078 $703,000
Q1 2019 May 14, 2019	BUY	$11.87 - $14.84 $832,609 - $1.04 Million	70,144 Added 112.56%	132,460 $1.88 Million
Q4 2018 Feb 13, 2019	BUY	$13.09 - $21.49 $118,975 - $195,322	9,089 Added 17.08%	62,316 $844,000
Q3 2018 Nov 13, 2018	SELL	$16.4 - $24.27 $8.05 Million - $11.9 Million	-491,023 Reduced 90.22%	53,227 $1.18 Million
Q2 2018 Aug 14, 2018	BUY	$13.95 - $20.2 $7.59 Million - $11 Million	544,250 New	544,250 $8.93 Million

Others Institutions Holding AMRX

# of Institutions

257

Shares Held

150M

Call Options Held

357K

Put Options Held

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.76B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account